Israel
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 15.85 B
|
Dec. 31, 2023 | USD 20.86 | -2.64% |
|
Israel |
|
2 |
USD 3.46 B
|
Dec. 31, 2023 | USD 43.58 | 0.94% |
|
Israel |
|
3 |
USD 492.05 M
|
Dec. 31, 2023 | USD 16.07 | 0.63% |
|
Israel |
|
4 |
USD 452.63 M
|
Dec. 31, 2023 | USD 0.52 | -0.27% |
|
Israel |
|
5 |
USD 359.29 M
|
Dec. 31, 2023 | USD 0.45 | 2.89% |
|
Israel |
|
6 |
USD 256.38 M
|
Dec. 31, 2023 | USD 20.06 | -0.66% |
|
Israel |
|
7 |
USD 202.13 M
|
Dec. 31, 2023 | USD 3.45 | -0.67% |
|
Israel |
|
8 |
USD 142.52 M
|
Dec. 31, 2023 | USD 7.30 | -3.84% |
|
Israel |
|
9 |
USD 97.92 M
|
Dec. 31, 2023 | USD 1.65 | -1.71% |
|
Israel |
|
10 |
USD 88.59 M
|
Dec. 31, 2023 | USD 3.80 | 0.26% |
|
Israel |
|
11 |
USD 45.60 M
|
Dec. 31, 2023 | USD 1.72 | 0.14% |
|
Israel |
|
12 |
USD 41.40 M
|
Dec. 31, 2023 | USD 0.84 | 0.91% |
|
Israel |
|
13 |
USD 36.82 M
|
Dec. 31, 2023 | USD 2.26 | -2.59% |
|
Israel |
|
14 |
USD 33.46 M
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
15 |
USD 31.79 M
|
Dec. 31, 2023 | USD 4.83 | -0.52% |
|
Israel |
|
16 |
USD 25.06 M
|
Dec. 31, 2023 | USD 1.20 | 0.92% |
|
Israel |
|
17 |
USD 18.69 M
|
Dec. 31, 2023 | USD 19.02 | 3.99% |
|
Israel |
|
18 |
USD 12.18 M
|
Dec. 31, 2023 | USD 0.11 | 0.81% |
|
Israel |
|
19 |
USD 9.58 M
|
Dec. 31, 2023 | USD 0.08 | 0.04% |
|
Israel |
|
20 |
USD 8.23 M
|
Dec. 31, 2023 | USD 0.07 | 0.45% |
|
Israel |
|
21 |
USD 6.51 M
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
22 |
USD 6.21 M
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
23 |
USD 4.80 M
|
Dec. 31, 2023 | USD 0.01 | -11.50% |
|
Israel |
|
24 |
USD 3.23 M
|
Dec. 31, 2023 | USD 1.24 | 5.08% |
|
Israel |
|
25 |
USD 2.77 M
|
Dec. 31, 2023 | USD 1.21 | 0.04% |
|
Israel |
|
26 |
USD 2.75 M
|
Dec. 31, 2023 | USD 2.58 | -3.90% |
|
Israel |
|
27 |
USD 743.00 K
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
28 |
USD 508.96 K
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
29 |
USD 326.00 K
|
June 30, 2024 | USD 4.33 | -2.68% |
|
Israel |
|
30 |
USD 241.26 K
|
Dec. 31, 2023 | USD 0.20 | -2.14% |
|
Israel |
|
31 |
USD 195.80 K
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
32 |
USD 39.11 K
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
33 |
USD 32.50 K
|
Dec. 31, 2023 | USD 1.69 | 1.00% |
|
Israel |
|
34 |
USD 4.41 K
|
Dec. 31, 2023 | USD 0.20 | 2.02% |
|
Israel |
|
35 |
USD 0.00
|
Dec. 31, 2023 | USD 0.00 | -99.04% |
|
Israel |
|
36 |
USD 0.00
|
Dec. 31, 2023 | USD 0.04 | -0.60% |
|
Israel |
|
37 |
USD 0.00
|
Dec. 31, 2023 | USD 4.33 | 4.29% |
|
Israel |
|
38 |
USD 0.00
|
Dec. 31, 2023 | USD 0.54 | -5.79% |
|
Israel |
|
39 |
USD 0.00
|
Dec. 31, 2023 | USD 0.02 | 1.63% |
|
Israel |
|
40 |
USD 0.00
|
Dec. 31, 2023 | USD 0.09 | -4.99% |
|
Israel |
|
41 |
USD 0.00
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
42 |
USD 0.00
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
43 |
USD 0.00
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
44 |
USD 0.00
|
Dec. 31, 2023 | USD 1.16 | -2.88% |
|
Israel |
|
45 |
USD 0.00
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
46 |
USD 0.00
|
Dec. 31, 2023 | USD 4.00 | 8.11% |
|
Israel |
|
47 |
USD 0.00
|
Dec. 31, 2023 | USD 0.19 | 2.52% |
|
Israel |
|
48 |
USD 0.00
|
Dec. 31, 2023 | USD 3.09 | 5.46% |
|
Israel |
|
49 |
USD 0.00
|
Dec. 31, 2023 | USD 1.90 | -4.04% |
|
Israel |
|
50 |
USD 0.00
|
Dec. 31, 2023 | USD 3.44 | 0.58% |
|
Israel |
The Pharmaceuticals company in Israel with the highest Revenue is Teva Pharmaceutical Industries Limited (Tel Aviv Stock Exchange: TEVA.TA) at USD 15.85 B.
The Pharmaceuticals company in Israel with the lowest Revenue is Scinai Immunotherapeutics Ltd. (NasdaqCM: SCNI) at USD 0.00.
The top 10 Pharmaceuticals companies in Israel by Revenue are Teva Pharmaceutical Industries Limited, Menora Mivtachim Holdings Ltd, InMode Ltd., Novolog (Pharm-Up 1966) Ltd, Sisram Medical Ltd, Ilex Medical Ltd, Nissan Medical Industries Ltd, Kamada Ltd., InterCure Ltd. and Rekah Pharmaceutical Industry Ltd..
The bottom 10 Pharmaceuticals companies in Israel by Revenue are Scinai Immunotherapeutics Ltd., Chemomab Therapeutics Ltd., PolyPid Ltd., Nextgen Biomed Ltd, Alpha Tau Medical Ltd., NeuroSense Therapeutics Ltd., Enlivex Therapeutics Ltd., Entera Bio Ltd., Galmed Pharmaceuticals Ltd. and PainReform Ltd..